The Nellcor™ pulse oximetry system with OxiMax™ technology establishes a new milestone in patient safety monitoring that can impact clinical settings from the everyday to the extraordinary. This new sensor design helps to more effectively monitor a broader range of patients, including those who may have been difficult to monitor in the past based on certain clinical considerations.
For more than 30 years, clinicians have trusted the Nellcor™ brand to provide fast, accurate and consistent pulse oximetry performance across the wide range of patient needs, from neonates to adults. These traits have helped make the Nellcor™ brand an industry leader in pulse oximetry.
OxiMax™ technology opens up a whole new world of pulse oximetry innovation that can help clinicians provide better patient care by more effectively monitoring a broader range of patients, including those who may have been difficult to monitor in the past based on certain clinical considerations.
View nearly 300 studies in this bibliography highlighting the benefits of Nellcor™ pulse oximetry in a wide variety of patients.
Following the NHS safety alert in Dec 2018, Medtronic offered their support to NHS Improvement with working together to achieve our common objective of patient safety. We have responded to this national safety alert with a customer letter mentioning our alliance with NHS and NAMDET (National Body for Medical Device Safety Officers) and have listed the new training materials we have available and which can be accessed in the 'Resources' section below.